Autoimmune Diseases
Clinical Review
Dermatologic Management of Hidradenitis Suppurativa and Impact on Pregnancy and Breastfeeding
It is important to be aware of how pregnancy may alter the treatment plan for women and impact their choice to breastfeed. The following review...
Original Research
Oral Lichen Planus Treated With Plasma Rich in Growth Factors
The use of plasma rich in growth factors (PRGF) is a treatment for erosive oral lichen planus (OLP) resistant to steroid therapy.
Case Reports
Interstitial Granulomatous Dermatitis as an Adverse Reaction to Vedolizumab
Reactive granulomatous dermatitis, interstitial granulomatous dermatitis (IGD) type, can occur as an adverse reaction to vedolizumab despite the...
Conference Coverage
Real-world data reinforce stem cell transplant for progressive systemic sclerosis
In real-world study, stem cell transplant provides major advantages for rapidly progressive systemic sclerosis if strict selection criteria are...
Hospital Consult
Current Recommendations for the Systemic Treatment of Cutaneous Lupus Erythematosus During Pregnancy
Cutaneous lupus erythematosus (CLE) is a heterogeneous autoimmune disease of the skin that commonly affects women of childbearing age. We describe...
Photo Challenge
Diffuse Urticarial Rash in a Pregnant Patient
A 29-year-old pregnant woman at 18 weeks and 5 days of gestation presented with a diffuse, pruritic, blistering rash of 5 weeks’ duration that...
Latest News
Lilly calls it quits on baricitinib’s development for lupus
The company said it is stopping phase 3 trials because of disappointing results.
Feature
Rituximab and COVID-19 vaccines: Studies begin to answer key questions
This article aims to summarize the latest research on how rituximab affects humoral and cell-mediated response following a COVID-19 vaccine...
From the Journals
Coronavirus leaves survivors with autoantibodies
“We would not normally expect to see such a diverse array of autoantibodies elevated in these individuals or stay elevated for as long...”
From the Journals
Oral JAK inhibitor continues to show promise for alopecia areata
There is currently no Food and Drug Administration–approved treatment for patients with moderate to severe alopecia areata.
Make the Diagnosis
A 22-year-old presented with erythematous papules on her fingers and toes
A 22-year-old with a history of ITP presented with 2 months of asymptomatic erythematous papules on her fingers and toes.